Quantitative susceptibility mapping of kidney inflammation and fibrosis in type 1 angiotensin receptor‐deficient mice

Disruption of the regulatory role of the kidneys leads to diverse renal pathologies; one major hallmark is inflammation and fibrosis. Conventional magnitude MRI has been used to study renal pathologies; however, the quantification or even detection of focal lesions caused by inflammation and fibrosis is challenging. We propose that quantitative susceptibility mapping (QSM) may be particularly sensitive for the identification of inflammation and fibrosis. In this study, we applied QSM in a mouse model deficient for angiotensin receptor type 1 (AT1). This model is known for graded pathologies, including focal interstitial fibrosis, cortical inflammation, glomerulocysts and inner medullary hypoplasia. We acquired high‐resolution MRI on kidneys from AT1‐deficient mice that were perfusion fixed with contrast agent. Two MR sequences were used (three‐dimensional spin echo and gradient echo) to produce three image contrasts: T1, T2* (magnitude) and QSM. T1 and T2* (magnitude) images were acquired to segment major renal structures and to provide landmarks for the focal lesions of inflammation and fibrosis in the three‐dimensional space. The volumes of major renal structures were measured to determine the relationship of the volumes to the degree of renal abnormalities and magnetic susceptibility values. Focal lesions were segmented from QSM images and were found to be closely associated with the major vessels. Susceptibilities were relatively more paramagnetic in wild‐type mice: 1.46 ± 0.36 in the cortex, 2.14 ± 0.94 in the outer medulla and 2.10 ± 2.80 in the inner medulla (10–2 ppm). Susceptibilities were more diamagnetic in knockout mice: –7.68 ± 4.22 in the cortex, –11.46 ± 2.13 in the outer medulla and –7.57 ± 5.58 in the inner medulla (10–2 ppm). This result was consistent with the increase in diamagnetic content, e.g. proteins and lipids, associated with inflammation and fibrosis. Focal lesions were validated with conventional histology. QSM was very sensitive in detecting pathology caused by small focal inflammation and fibrosis. QSM offers a new MR contrast mechanism to study this common disease marker in the kidney. Copyright © 2013 John Wiley & Sons, Ltd.

[1]  G. Maret,et al.  Orientation of Nucleic Acids in High Magnetic Fields , 1975 .

[2]  M. Fukunaga,et al.  Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure , 2010, Proceedings of the National Academy of Sciences.

[3]  M. Nangaku Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. , 2005, Journal of the American Society of Nephrology : JASN.

[4]  Rolf Gruetter,et al.  On the origin of the MR image phase contrast: An in vivo MR microscopy study of the rat brain at 14.1 T , 2009, NeuroImage.

[5]  C. Moonen,et al.  A fast calculation method for magnetic field inhomogeneity due to an arbitrary distribution of bulk susceptibility , 2003 .

[6]  N. Alenina,et al.  Developmental renin expression in mice with a defective renin-angiotensin system. , 2009, American journal of physiology. Renal physiology.

[7]  H. S. Kim,et al.  Genetic control of blood pressure and the angiotensinogen locus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Mannon,et al.  Regulation of blood pressure by the type 1A angiotensin II receptor gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  G. Allan Johnson,et al.  High-throughput morphologic phenotyping of the mouse brain with magnetic resonance histology , 2007, NeuroImage.

[10]  Yi Wang,et al.  Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: Validation and application to brain imaging , 2010, Magnetic resonance in medicine.

[11]  Bing Wu,et al.  Fast and tissue-optimized mapping of magnetic susceptibility and T2* with multi-echo and multi-shot spirals , 2012, NeuroImage.

[12]  Wei Li,et al.  3D fiber tractography with susceptibility tensor imaging , 2012, NeuroImage.

[13]  David J. Foran,et al.  Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma , 2015, Disease markers.

[14]  Tsutomu Inoue,et al.  Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging. , 2011, Journal of the American Society of Nephrology : JASN.

[15]  Yi Wang,et al.  Quantitative MR susceptibility mapping using piece‐wise constant regularized inversion of the magnetic field , 2008, Magnetic resonance in medicine.

[16]  H. S. Kim,et al.  Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Jeff H. Duyn,et al.  High-field MRI of brain cortical substructure based on signal phase , 2007, Proceedings of the National Academy of Sciences.

[18]  J. Reichenbach,et al.  Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. , 2010, Medical physics.

[19]  J. Charles Jennette,et al.  Male–female differences in fertility and blood pressure in ACE-deficient mice , 1995, Nature.

[20]  Chunlei Liu Susceptibility tensor imaging , 2010, Magnetic resonance in medicine.

[21]  Rajesh C. Dash,et al.  A γGT-AT1A receptor transgene protects renal cortical structure in AT1 receptor-deficient mice , 2004 .

[22]  L. Hedlund,et al.  Morphologic phenotyping with MR microscopy: the visible mouse. , 2002, Radiology.

[23]  M. Capecchi,et al.  Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[24]  J. Duyn,et al.  Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data , 2009, Magnetic resonance in medicine.

[25]  S. Herget-Rosenthal,et al.  Imaging techniques in the management of chronic kidney disease: current developments and future perspectives. , 2011, Seminars in nephrology.

[26]  M. Yanagita Inhibitors/antagonists of TGF-β system in kidney fibrosis. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  Yimei Zhu,et al.  Fast phase unwrapping algorithm for interferometric applications. , 2003, Optics letters.

[28]  Luke Xie,et al.  Magnetic Resonance Histology of Age-Related Nephropathy in the Sprague Dawley Rat , 2012, Toxicologic pathology.

[29]  Weiyu Xu,et al.  Accuracy of the Morphology Enabled Dipole Inversion (MEDI) Algorithm for Quantitative Susceptibility Mapping in MRI , 2012, IEEE Transactions on Medical Imaging.

[30]  D. Yablonskiy,et al.  Biophysical mechanisms of phase contrast in gradient echo MRI , 2009, Proceedings of the National Academy of Sciences.

[31]  Bing Wu,et al.  Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition , 2011, NeuroImage.

[32]  Yu-Chung N. Cheng,et al.  Susceptibility weighted imaging (SWI) , 2004, Zeitschrift fur medizinische Physik.

[33]  W. Helfrich,et al.  Magnetic anisotropy of lecithin membranes. A new anisotropy susceptometer. , 1984, Biophysical journal.

[34]  Bing Wu,et al.  Magnetic susceptibility anisotropy of human brain in vivo and its molecular underpinnings , 2012, NeuroImage.

[35]  T. Ichiki,et al.  Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. , 1995, The Journal of clinical investigation.

[36]  H. Thoeny,et al.  Science to practice: Can diffusion-weighted MR imaging findings be used as biomarkers to monitor the progression of renal fibrosis? , 2010, Radiology.

[37]  Rudolf Stollberger,et al.  Automated unwrapping of MR phase images applied to BOLD MR‐venography at 3 Tesla , 2003, Journal of magnetic resonance imaging : JMRI.

[38]  K. Bae,et al.  Imaging for the prognosis of autosomal dominant polycystic kidney disease , 2010, Nature Reviews Nephrology.